Targeting FGF for third-line treatment of mRCC

被引:0
|
作者
Sarah Payton
机构
关键词
D O I
10.1038/nrurol.2014.55
中图分类号
学科分类号
摘要
引用
收藏
页码:186 / 186
相关论文
共 50 条
  • [41] Patient Perceptions Impact Progression to Third-Line Therapy for Treatment of Overactive Bladder
    Iyer, Shilpa
    Amegashie, Courtney
    deMartelly, Victoria
    Letko, Juraj
    Glass, Dianne
    Fetzer, Laura
    Botros, Sylvia
    Wroblewski, Kristen
    Valaitis, Sandra
    [J]. JOURNAL OF UROLOGY, 2021, 206 (05): : 1241 - 1246
  • [42] A case of the third-line treatment of lung adenocarcinoma using nivolumab combined with anlotinib
    Yang, Ye
    Li, Junjie
    Yu, Ping
    Ge, Jun
    Liu, Bin
    Li, Juan
    [J]. PHARMAZIE, 2021, 76 (07): : 338 - 340
  • [43] Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review
    Chan, Wing-lok
    Lam, Ka-on
    So, Tsz-him
    Lee, Victor Ho-fun
    Kwong, Lai-wan Dora
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [44] Second- or third-line chemotherapy in NSCLC
    Sorensen, JB
    [J]. LUNG CANCER, 2004, 45 : S18 - S18
  • [45] A Decade of Progress: Advances in the Third-Line Treatment of Patients With Metastatic Colorectal Cancer
    Bekaii-Saab, Tanios
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (02): : S23 - S30
  • [46] Is there a third-line therapy for metastatic colorectal cancer?
    Grothey, Axel
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (06) : S36 - S38
  • [47] Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer
    Kawakami, Takeshi
    Machida, Nozomu
    Yasui, Hirofumi
    Kawahira, Masahiro
    Kawai, Sadayuki
    Kito, Yosuke
    Yoshida, Yukio
    Hamauchi, Satoshi
    Tsushima, Takahiro
    Todaka, Akiko
    Yokota, Tomoya
    Yamazaki, Kentaro
    Fukutomi, Akira
    Onozawa, Yusuke
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 809 - 814
  • [48] Clinical impact of oral intake in third-line treatment for advanced gastric cancer
    Ogata, T.
    Narita, Y.
    Kumanishi, R.
    Nakazawa, T.
    Matsubara, Y.
    Kato, K.
    Nozawa, K.
    Honda, K.
    Masuishi, T.
    Bando, H.
    Kadowaki, S.
    Ando, M.
    Tajika, M.
    Muro, K.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S141 - S141
  • [49] Oral trimethoprim: a relatively safe and successful third-line treatment for acne vulgaris
    Cunliffe, WJ
    Aldana, OL
    Goulden, V
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 (04) : 757 - 758
  • [50] Fatal progressive cerebral ischemia in CML under third-line treatment with ponatinib
    K Mayer
    G H Gielen
    W Willinek
    M C Müller
    D Wolf
    [J]. Leukemia, 2014, 28 : 976 - 977